Economic Liberties Calls for Senate Vote on Hospitality Junk Fees Ban
June 12, 2024 — In response to news that the US House has passed Rep. Young Kim and Rep. Kathy Castor’s No Hidden FEES Act, a bill to ban deceptive junk fees in hotels and other forms of short-term lodging, in a landslide bipartisan vote of 384-25, the American Economic Liberties Project released the following statement.
Anti-Monopoly Advocates Call for DOJ Investigation into YouTube’s Market Dominance
June 12, 2024 — Today, the American Economic Liberties Project, Demand Progress and a coalition of 9 other advocacy groups sent a letter to the Department of Justice Antitrust Division urging an immediate investigation into YouTube’s alarming market dominance and anticompetitive practices.
Landmark CFPB Rule Lifts Medical Debt Burden from Consumers’ Financial Health
June 11, 2024 — In response to news that the Consumer Financial Protection Bureau (CFPB) has proposed a rule that would eliminate nearly $49 billion of medical debt that unfairly and inaccurately lowers credit scores for 15 million Americans—preventing them from accessing loans and other financial products—the American Economic Liberties Project released the following statement.
New Policy Roadmap Explains How States Can End Noncompetes and TRAPs
June 11, 2024 — Following the Federal Trade Commission’s final rule to ban noncompete agreements, the American Economic Liberties Project today released a policy brief with model legislation, “Better Wages and Working Conditions: How States Should Tackle Noncompete Agreements, ‘TRAPs,’ and Other Restraints On Worker Mobility,” which provides a roadmap for state lawmakers to compliment federal regulation to end these exploitative practices.
Court Invalidates Teva’s Improper Patents that Keep Inhaler Prices High, Embracing FTC Amicus Brief
June 10, 2024 — Following a decision from the United States District Court for the District of New Jersey ordering Teva Pharmaceuticals to correct or delete five improperly listed Orange Book patents for its ProAir Inhalers, the American Economic Liberties Project released the following statement.